Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

Status:
Terminated

Trial end date:
2010-03-01

Target enrollment:

Participant gender:

The purpose of this study is to demonstrate that dutogliptin/PHX1149T is safe and tolerable.

Phase 2

Phenomix